COVID-KOSHA
Home
Help
(current)
Comment
!
Note: Language translations may be imperfect
A model anti-pandemic portal for scientists & public
High priority articles (R1, Most articles most likely to be relevant):
Second priority articles (R2, Moderate portion of articles likely to be relevant):
Other articles (R3, Lesser portion of articles likely to be relevant):
Clinical Trials and Similar Human Studies
Last updated: 2025 Mar 18
Total hit(s): 22668
S.No.
PMID
Ascending order
Descending order
Title
Ascending order
Descending order
Journal Name
Ascending order
Descending order
Publish Date
Ascending order
Descending order
Impact Factor
Ascending order
Descending order
Citations
Ascending order
Descending order
Auto summary
Ascending order
Descending order
1
39635731
Nationwide seroprevalence of SARS-CoV-2 Delta variant and five Omicron sublineages in companion cats and dogs in the USA: insights into their role in COVID-19 epidemiology.
Emerg Microbes Infect
2025 Dec
5.84
1
2
39887328
Willingness to pay for the effect of SARS-CoV-2 antivirals in preventing COVID-19 transmission to others in the Japanese population.
J Med Econ
2025 Dec
1
3
39794268
Controlling the COVID-19 pandemic through vaccination: a perspective from Indonesia.
Expert Rev Vaccines
2025 Dec
4.37
1
N/A
4
39720838
Immunogenicity and safety of SARS-CoV-2 recombinant protein vaccine (CHO cell) LYB001 as a heterologous booster following two- or three-dose inactivated COVID-19 vaccine in adults aged >/=18 years: interim results of a randomized, active-controlled, double-blinded, phase 3 trial.
Expert Rev Vaccines
2025 Dec
4.37
1
5
40028815
Impact of FcRn antagonism on vaccine-induced protective immune responses against viral challenge in COVID-19 and influenza mouse vaccination models.
Hum Vaccin Immunother
2025 Dec
4.7
1
6
40032512
Involvement of oxidative stress in post-acute sequelae of COVID-19: clinical implications.
Redox Rep
2025 Dec
1
7
40051347
Limitations of neutralizing antibody titers in COVID-19 vaccine efficacy trials and a call for additional correlates of protection.
Hum Vaccin Immunother
2025 Dec
4.7
1
8
39865693
Immunogenicity and safety of a COVID-19 DNA vaccine in healthy adults and elderly: A randomized, observer-blind, placebo-controlled phase 2 trial.
Hum Vaccin Immunother
2025 Dec
4.7
1
9
39834144
Sustained immunogenicity of bivalent protein COVID-19 vaccine SCTV01C against antigen matched and mismatched variants.
Expert Rev Vaccines
2025 Dec
4.37
1
10
39911527
Multisystem inflammatory syndrome in children (MIS-C) associated with COVID-19, clinical characteristics: A multi-center observational study from Jordan.
Glob Epidemiol
2025 Jun
- n/a -
1
11
40046771
Production and cryo-electron microscopy structure of an internally tagged SARS-CoV-2 spike ecto-domain construct.
J Struct Biol X
2025 Jun
1
12
39963202
Cigarette Smoking Patterns Among Racial and Ethnic Groups With Chronic Lung Diseases During the COVID-19 Pandemic.
AJPM Focus
2025 Jun
1
13
39802435
Corrigendum to "LogNNet model as a fast, simple and economical AI instrument in the diagnosis and prognosis of COVID-19" [MethodsX 10 (2023) 102194].
MethodsX
2025 Jun
1
14
39987705
Decoding SARS-CoV-2 variants: Mutations, viral stability, and breakthroughs in vaccines and therapies.
Biophys Chem
2025 May-Jun
1.75
1
15
39894142
Validation and clinical performance of a non-commercial ELISA for SARS-CoV-2 anti-RBD IgA antibodies.
Anal Biochem
2025 May
1
16
39986580
COVID-19 and our understanding of vitamin D and immune function.
J Steroid Biochem Mol Biol
2025 May
3.63
1
17
39837378
In-vivo implementation of the HPTLC methodology to rat plasma for the concurrent determination of a novel combination therapy for the management of COVID-19 (favipiravir and nitazoxanide).
Anal Biochem
2025 May
1
18
39983537
SARS-CoV-2 seroreversion and all-cause mortality in nursing home residents and staff post-primary course vaccination in Belgium between February and December 2021.
Vaccine
2025 Apr 2
3.31
1
19
39847906
Hyperplex PCR enables highly multiplexed analysis of point mutations in wastewater: Long-term SARS-CoV-2 variant surveillance in Sweden as a case study.
Water Res
2025 Apr 15
8.14
1
20
40043614
Structure and dynamics of Alpha B.1.1.7 SARS-CoV-2 S-protein in complex with Fab of neutralizing antibody REGN10987.
Biochem Biophys Res Commun
2025 Apr 1
2.73
1
21
40023068
Exploring the therapeutic potential of HAPC in COVID-19-induced acute lung injury.
Phytomedicine
2025 Apr
7.2
1
22
39884914
The immunopathogenesis of a cytokine storm: The key mechanisms underlying severe COVID-19.
Cytokine Growth Factor Rev
2025 Apr
5.5
1
23
40025551
Association of TNFRSF13B Gene Polymorphisms With SARS-CoV-2 Infection, Severity, and Humoral Immune Response in a Moroccan Population.
Int J Immunogenet
2025 Apr
1
24
40061153
Health and Economic Impact of COVID-19 Surveillance Testing in Seattle Homeless Shelters: A Cost-Effectiveness Analysis.
AJPM Focus
2025 Apr
1
25
40051670
The Prognostic Value of Circulating Cytokines and Complete Blood Count-Based Inflammatory Markers in COVID-19 Patients With Atrial Fibrillation.
Cardiol Res
2025 Apr
- n/a -
1